Takeda, Sanofi’s Diabetic Drug, Nesina Approved For Launch In China
This article was originally published in PharmAsia News
Executive Summary
Takeda Pharmaceutical Co. Ltd. and Sanofi gained government approval to launch diabetes drug Nesina (alogliptin) in China, which is to be the country’s first diabetic drug with evidence-backed cardiovascular safety.